To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Dipropanoylmorphine is an opiate derivative, the 3,6-dipropanoyl ester of morphine. It was developed in the 1970s as an analgesic.  It is rarely used in some countries for the relief of severe pain such as that caused by terminal cancer, as an alternative to diamorphine (heroin) and morphine.
Additional recommended knowledge
Dipropanoylmorphine is slightly slower acting than diamorphine, but longer lasting, and is slightly more potent due to its relatively higher lipophilicity.  Side effects are similar to those of other opioids and include itching, nausea and respiratory depression.
Dipropanoylmorphine is prepared by reacting morphine with propanoic anhydride, in an analogous manner to how heroin is produced by reacting morphine with acetic anhydride.
While acetic anhydride is a restricted chemical around the world due to its potential uses in making heroin, it is used in vast amounts by the chemical industry for the manufacture of drugs such as aspirin. Propanoic anhydride however is much less widely used. Although it is used in the manufacture of a range of pharmaceuticals, none of these are produced in nearly as large quantities, and sales of propanoic anhydride in quantities larger than one gram must be reported in many countries because of its potential use in making fentanyl type synthetic opiates.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dipropanoylmorphine". A list of authors is available in Wikipedia.|